These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15140051)

  • 1. Serum amyloid P-component-mediated inhibition of the uptake of Mycobacterium tuberculosis by macrophages, in vitro.
    Kaur S; Singh PP
    Scand J Immunol; 2004 May; 59(5):425-31. PubMed ID: 15140051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute-phase reactants during murine tuberculosis: unknown dimensions and new frontiers.
    Singh PP; Kaur S
    Tuberculosis (Edinb); 2005; 85(5-6):303-15. PubMed ID: 16275064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid P-component in murine tuberculosis: induction kinetics and intramacrophage Mycobacterium tuberculosis growth inhibition in vitro.
    Singh PP; Kaur S
    Microbes Infect; 2006 Feb; 8(2):541-51. PubMed ID: 16298151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of colony-stimulating factors by a 30-kDa secretory protein of Mycobacterium tuberculosis H37Rv.
    Kaur S; Kaur H; Singh PP
    Eur Cytokine Netw; 2004; 15(4):327-38. PubMed ID: 15627642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages.
    Bijl M; Horst G; Bijzet J; Bootsma H; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2003 Jan; 48(1):248-54. PubMed ID: 12528126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoarabinomannan inhibits nonopsonic binding of Mycobacterium tuberculosis to murine macrophages.
    Stokes RW; Speert DP
    J Immunol; 1995 Aug; 155(3):1361-9. PubMed ID: 7636201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of CD11b knockout mice to characterize the role of complement receptor 3 (CR3, CD11b/CD18) in the growth of Mycobacterium tuberculosis in macrophages.
    Melo MD; Catchpole IR; Haggar G; Stokes RW
    Cell Immunol; 2000 Oct; 205(1):13-23. PubMed ID: 11078603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacteria-macrophage interactions. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages.
    Stokes RW; Haidl ID; Jefferies WA; Speert DP
    J Immunol; 1993 Dec; 151(12):7067-76. PubMed ID: 8258711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages.
    van Rossum AP; Fazzini F; Limburg PC; Manfredi AA; Rovere-Querini P; Mantovani A; Kallenberg CG
    Arthritis Rheum; 2004 Aug; 50(8):2667-74. PubMed ID: 15334483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cellular activation and tumor necrosis factor-alpha in the early expression of Mycobacterium tuberculosis 85B mRNA in human alveolar macrophages.
    Islam N; Kanost AR; Teixeira L; Johnson J; Hejal R; Aung H; Wilkinson RJ; Hirsch CS; Toossi Z
    J Infect Dis; 2004 Jul; 190(2):341-51. PubMed ID: 15216471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient.
    Stokes RW; Thorson LM; Speert DP
    J Immunol; 1998 Jun; 160(11):5514-21. PubMed ID: 9605155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum amyloid P-component-induced colony-stimulating factors production by macrophages.
    Singh S; Singh PP
    Scand J Immunol; 2001 Feb; 53(2):155-61. PubMed ID: 11169219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dying cells program their expedient disposal: serum amyloid P component upregulation in vivo and in vitro induced by photodynamic therapy of cancer.
    Merchant S; Sun J; Korbelik M
    Photochem Photobiol Sci; 2007 Dec; 6(12):1284-9. PubMed ID: 18046483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-mediated binding of the acute-phase reactant mouse serum amyloid P-component (SAP) to macrophages.
    Siripont J; Tebo JM; Mortensen RF
    Cell Immunol; 1988 Dec; 117(2):239-52. PubMed ID: 3143483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate responses to Mycobacterium leprae infections--C reactive protein in man and serum amyloid P in mice.
    Thompson RA; Sukumaran KD; Rajagopalan K
    Clin Exp Immunol; 1985 Aug; 61(2):329-35. PubMed ID: 4042426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of human serum amyloid P componentto L-selectin.
    Stibenz D; Gräfe M; Debus N; Hasbach M; Bahr I; Graf K; Fleck E; Thanabalasingam U; Bührer C
    Eur J Immunol; 2006 Feb; 36(2):446-56. PubMed ID: 16421944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of complement receptor 3 results in reduced binding and ingestion of Mycobacterium tuberculosis but has no significant effect on the induction of reactive oxygen and nitrogen intermediates or on the survival of the bacteria in resident and interferon-gamma activated macrophages.
    Rooyakkers AW; Stokes RW
    Microb Pathog; 2005 Sep; 39(3):57-67. PubMed ID: 16084683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania donovani amastigote components-induced colony-stimulating factors production.
    Singal P; Singh PP
    Parasitol Int; 2005 Mar; 54(1):9-20. PubMed ID: 15710545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P.
    Ezzahiri R; Stassen FR; Kurvers HR; Dolmans V; Kitslaar PJ; Bruggeman CA
    APMIS; 2006 Feb; 114(2):117-26. PubMed ID: 16519748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.